Biotech startups can provide faster, more agile responses to new diseases
Marrus ’23 – (Stephanie; Life Science Entrepreneurship Program, University of California; “Increasing the success potential of promising biotech companies”; January 18, 2023; Nature Biotechnology; https://www.nature.com/articles/s41587-022-01627-1 MV)
Biotech startups benefit society by solving unmet scientific and medical needs, but more can be done to move their technologies to market more quickly.
The recent SARS-CoV-2, monkeypox, poliovirus, and RSV outbreaks remind us of the importance of agile biotechnology companies. We need to reduce the hurdles and time it takes for future BioNTechs and Modernas to find their flow. Successful biotech startups will continue to benefit society by solving formerly intractable scientific and medical problems, but only when they can deliver a viable business model. How can we move more of these technologies to market more quickly?